ICOSABUTATE, A NOVEL ORAL FREE FATTY ACID RECEPTOR 4 (FFAR4) AGONIST, SIGNIFICANTLY DECREASES BIOMARKERS OF NASH AND FIBROSIS INDEPENDENT OF DISEASE SEVERITYNaim Alkhouri,Ann C. Moore,Anita Kohli,Rashmee Patil,Nadege Gunn,Madhavi Rudraraju,Stephen Rossi,David Fraser,Carine Beysen,Stephen A. HarrisonHEPATOLOGY(2021)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要